Published in Sci Rep on March 17, 2017
Proteases Revisited: Roles and Therapeutic Implications in Fibrosis. Mediators Inflamm (2017) 0.75
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med (2010) 13.33
Steatohepatitis: a tale of two "hits"? Gastroenterology (1998) 13.21
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med (2014) 9.40
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol (2000) 8.49
Human fatty liver disease: old questions and new insights. Science (2011) 8.03
Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell (2005) 7.04
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet (2014) 6.84
Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med (2012) 6.15
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet (2011) 5.94
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology (2003) 4.84
Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem (2006) 3.57
A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol (2010) 3.53
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology (2004) 3.23
Cellular and molecular mechanisms of liver injury. Gastroenterology (2008) 3.02
Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol (2004) 2.70
Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol (1995) 2.55
Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J Hepatol (2003) 2.29
Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol (2004) 1.97
Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J Pharmacol (2008) 1.90
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol (2012) 1.87
C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes (2010) 1.86
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Hepatology (2009) 1.79
Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiol Cell Physiol (2012) 1.70
Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells. Clin Exp Pharmacol Physiol (2009) 1.61
Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation (2006) 1.38
Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C. Hepatology (2007) 1.38
Pirfenidone effectively reverses experimental liver fibrosis. J Hepatol (2002) 1.27
Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis. Eur Respir J (2004) 1.23
Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis. J Hepatol (2010) 1.23
Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level. Am J Physiol (1999) 1.21
Death receptor-mediated liver injury. Semin Liver Dis (2007) 1.18
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis. Hepatology (2011) 1.12
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. Liver Int (2014) 1.07
Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis C. Aliment Pharmacol Ther (2010) 1.07
Pirfenidone improves renal function and fibrosis in the post-obstructed kidney. Kidney Int (1998) 1.06
Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis. Am J Pathol (2011) 1.01
Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. Clin Exp Pharmacol Physiol (2001) 0.96
Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents. Hepatology (2013) 0.95
Renoprotective properties of pirfenidone in subtotally nephrectomized rats. Eur J Pharmacol (2009) 0.93
Deadly liaisons: fatal attraction between CCN matricellular proteins and the tumor necrosis factor family of cytokines. J Cell Commun Signal (2009) 0.93
Apoptosis and angiogenesis: an evolving mechanism for fibrosis. FASEB J (2013) 0.93
Liver sinusoidal endothelial cells link hyperinsulinemia to hepatic insulin resistance. Diabetes (2013) 0.89
Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats. Br J Pharmacol (2002) 0.89
Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans. PLoS One (2013) 0.87
Potent antioxidant role of pirfenidone in experimental cirrhosis. Eur J Pharmacol (2008) 0.87
A caspase-8-independent signaling pathway activated by Fas ligation leads to exposure of the Bak N terminus. J Biol Chem (2004) 0.84
Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C. BMC Gastroenterol (2014) 0.79
Genome-wide copy number analysis and systematic mutation screening in 58 patients with hypogonadotropic hypogonadism. Fertil Steril (2014) 1.43
Epimutations of the IG-DMR and the MEG3-DMR at the 14q32.2 imprinted region in two patients with Silver-Russell Syndrome-compatible phenotype. Eur J Hum Genet (2014) 1.11
Human genetic variation database, a reference database of genetic variations in the Japanese population. J Hum Genet (2016) 1.00
Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction. PLoS One (2016) 0.97
Absence of Maternal Methylation in Biparental Hydatidiform Moles from Women with NLRP7 Maternal-Effect Mutations Reveals Widespread Placenta-Specific Imprinting. PLoS Genet (2015) 0.91
Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions. Nat Biotechnol (2016) 0.86
Identical NR5A1 Missense Mutations in Two Unrelated 46,XX Individuals with Testicular Tissues. Hum Mutat (2016) 0.84
Genome-wide multilocus imprinting disturbance analysis in Temple syndrome and Kagami-Ogata syndrome. Genet Med (2016) 0.82
Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion. Br J Haematol (2015) 0.79
Repeated fecal microbiota transplantation in a child with ulcerative colitis. Pediatr Int (2016) 0.78
Compilation of copy number variants identified in phenotypically normal and parous Japanese women. J Hum Genet (2014) 0.77
Case of pachydermoperiostosis with solute carrier organic anion transporter family, member 2A1 (SLCO2A1) mutations. J Dermatol (2015) 0.77
Human Oocyte-Derived Methylation Differences Persist in the Placenta Revealing Widespread Transient Imprinting. PLoS Genet (2016) 0.76
DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status. PLoS One (2015) 0.75
Beckwith-Wiedemann syndrome and pseudohypoparathyroidism type Ib in a patient with multilocus imprinting disturbance: a female-dominant phenomenon? J Hum Genet (2016) 0.75
Nucleotide substitutions in CD101, the human homolog of a diabetes susceptibility gene in non-obese diabetic mouse, in patients with type 1 diabetes. J Diabetes Investig (2016) 0.75
Somatic HRAS p.G12S mosaic mutation causes unilaterally distributed epidermal nevi, woolly hair and palmoplantar keratosis. J Dermatol (2017) 0.75
Paradoxical gain-of-function mutant of the G-protein-coupled receptor PROKR2 promotes early puberty. J Cell Mol Med (2017) 0.75
Changeability of the fully methylated status of the 15q11.2 region in induced pluripotent stem cells derived from a patient with Prader-Willi syndrome. Congenit Anom (Kyoto) (2016) 0.75
Molecular mechanism of obesity-induced "metabolic" tissue remodeling. J Diabetes Investig (2017) 0.75
The HUS1B promoter is hypomethylated in the placentas of low-birth-weight infants. Gene (2016) 0.75
Comprehensive screening for monogenic diabetes in 89 Japanese children with insulin-requiring antibody-negative type 1 diabetes. Pediatr Diabetes (2017) 0.75
Human cytomegalovirus downregulates SLITRK6 expression through IE2. J Neurovirol (2016) 0.75
Complete type of pachydermoperiostosis with a novel mutation c.510G>A of the SLCO2A1 gene. J Dermatol (2016) 0.75
Salvage of fetal karyotype information from SNP array data obtained from products of conception with maternal cell contamination. Prenat Diagn (2017) 0.75
Involvement of prostaglandin E2 in the first Japanese case of pachydermoperiostosis with HPGD mutation and recalcitrant leg ulcer. J Dermatol Sci (2015) 0.75
Genomic analysis of two rare cases of pediatric Ph-positive T-ALL. Pediatr Blood Cancer (2021) 0.75
Synthetic "smart gel" provides glucose-responsive insulin delivery in diabetic mice. Sci Adv (2017) 0.75
An Alpha-kinase 2 Gene Variant Disrupts Filamentous Actin Localization in the Surface Cells of Colorectal Cancer Spheroids. Anticancer Res (2017) 0.75
Biallelic mutations in SZT2 cause a discernible clinical entity with epilepsy, developmental delay, macrocephaly and a dysmorphic corpus callosum. Brain Dev (2017) 0.75
Infiltration of mast cells in pachydermia of pachydermoperiostosis. J Dermatol (2017) 0.75
CTCF deletion syndrome: clinical features and epigenetic delineation. J Med Genet (2017) 0.75
Direct platelet adhesion potentiates group 2 innate lymphoid cell functions. Allergy (2021) 0.75
Gut Hormone GIP Induces Inflammation and Insulin Resistance in the Hypothalamus. Endocrinology (2020) 0.75